RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,497 | -33.0% | 31,807 | 0.0% | 0.45% | +70.8% |
| Q2 2023 | $399,496 | -23.7% | 31,807 | 0.0% | 0.26% | -29.0% |
| Q1 2023 | $523,861 | +10.2% | 31,807 | 0.0% | 0.37% | -77.6% |
| Q4 2022 | $475,197 | -33.3% | 31,807 | 0.0% | 1.66% | -29.1% |
| Q3 2022 | $712,000 | +33.6% | 31,807 | 0.0% | 2.34% | +79.3% |
| Q2 2022 | $533,000 | -30.0% | 31,807 | +25.1% | 1.31% | -0.5% |
| Q1 2022 | $761,000 | -2.6% | 25,425 | 0.0% | 1.31% | +48.4% |
| Q4 2021 | $781,000 | +14.0% | 25,425 | +17.0% | 0.88% | +23.8% |
| Q3 2021 | $685,000 | -13.8% | 21,723 | 0.0% | 0.72% | -21.2% |
| Q2 2021 | $795,000 | +15.2% | 21,723 | +8.9% | 0.91% | -1.1% |
| Q1 2021 | $690,000 | +101.2% | 19,952 | +141.8% | 0.92% | +94.3% |
| Q4 2020 | $343,000 | -2.3% | 8,250 | 0.0% | 0.47% | -29.1% |
| Q3 2020 | $351,000 | – | 8,250 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |